More than 30 Coronavirus Vaccine Candidates In Development

More than 30 Coronavirus Vaccine Candidates In Development – India

Indian Researchers Update PM Modi About More than 30 Coronavirus Vaccine Candidates in Development

Prime Minister Narendra Modi has been informed by the researchers that more than 30 coronavirus vaccine candidates are in different stages of development currently in India. They also said that a few of the vaccine candidates are moving forward to trial stages.

To gauge India’s progress in finding a cure, PM Modi chaired a meeting of the task force on coronavirus vaccine development. He took a detailed review of COVID-19 testing, diagnosis, drug discovery, and vaccine development.

Indian companies have come across as innovators in early-stage vaccine development research, stated the Prime Minister’s Office statement released after the meeting. Details on a three-pronged plan for the development of a vaccine

were added in the statement. Repurposing existing drugs is the first. At least four drugs are undergoing examination and synthesis as of now.

The statement added, “Secondly, by linking high performance computational approached with laboratory verification, the development of new candidate drugs and molecules are being driven. Thirdly, for finding general anti-viral properties, plant extracts and products are being examined.”

To oversee the progress on vaccine development and drug testing, the government constituted a national task force last month. Connecting international collaborations, research institutions, and academia, in drug testing and vaccine development, this task force acts as a bridge. The representatives from the drug controller general of India (DCGI), directorate general of health services (DGHS), defense research and development organization (DRDO), the council of scientific and industrial research (CSIR), Department of Biotechnology (DBT), department of science and technology (DST), Indian Council of Medical Research (ICMR), and the Ministry of AYUSH. A Niti Aayog member Dr. Vinod Paul and a principal scientific advisor to the government of India, K Vijay Raghavan co-chaired this task force.


More than 30 Coronavirus Vaccine Candidates In Development